CDH1 and neoplasm: By immunohistochemistry, the tumor showed a triple-negative breast cancer (TNBC) phenotype (ER−/PR−/HER2-), negative for E-cadherin (Fig. 3c), positive for GATA-3 (Fig. 3d), and the Ki-67 index was approximately 40%.